These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 30626077)

  • 1. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.
    Kawauchi H; Yanai K; Wang DY; Itahashi K; Okubo K
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.
    Ansotegui IJ; Bousquet J; Canonica GW; Demoly P; Gómez RM; Meltzer EO; Murrieta-Aguttes M; Naclerio RM; Rosario Filho N; Scadding GK
    Curr Med Res Opin; 2024 Aug; 40(8):1297-1309. PubMed ID: 39028636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abdelshafy AM; Abdallah SY; Hassan AF; Mohamed HA; Kamal NM; Ali ST; Abdelhaleem IA
    Am J Rhinol Allergy; 2022 Sep; 36(5):684-694. PubMed ID: 35593100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines.
    Gillman S; Gillard M; Strolin Benedetti M
    Allergy Asthma Proc; 2009; 30(4):366-76. PubMed ID: 19335943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma.
    Bachert C; Maspero J
    J Asthma; 2011 Nov; 48(9):965-73. PubMed ID: 21970671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical pharmacology of non-sedating antihistamines.
    Yanai K; Yoshikawa T; Yanai A; Nakamura T; Iida T; Leurs R; Tashiro M
    Pharmacol Ther; 2017 Oct; 178():148-156. PubMed ID: 28457804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
    Church MK; Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos NG; Rodriguez Del Rio P;
    Expert Rev Clin Immunol; 2023; 19(7):813-820. PubMed ID: 37191185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilastine as a potential treatment in allergic rhinitis.
    Kowal K; DuBuske L
    Am J Rhinol Allergy; 2014; 28(4):312-6. PubMed ID: 25197918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Antihistamines and their Properties used for Treatment of Different Diseases.
    Chaudhari R; Gosavi S; Bornare P; Sonawane S; Ahire T
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(4):220-229. PubMed ID: 38018180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
    Jáuregui I; Ramaekers JG; Yanai K; Farré M; Redondo E; Valiente R; Labeaga L
    Expert Opin Drug Saf; 2016 Jan; 15(1):89-98. PubMed ID: 26571227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihistamines: ABC for the pediatricians.
    Parisi GF; Licari A; Papale M; Manti S; Salpietro C; Marseglia GL; Leonardi S
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():34-36. PubMed ID: 32017222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antihistamines in asthma therapy: is there a protective effect?
    Walsh GM
    Am J Respir Med; 2002; 1(1):27-34. PubMed ID: 14720073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihistamine therapy in allergic rhinitis.
    Hoyte FC; Katial RK
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):509-43. PubMed ID: 21737041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihistamines on innate immune responses to severe bacterial infection in mice.
    Metz M; Doyle E; Bindslev-Jensen C; Watanabe T; Zuberbier T; Maurer M
    Int Arch Allergy Immunol; 2011; 155(4):355-60. PubMed ID: 21346365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.